144 related articles for article (PubMed ID: 31108196)
1. Ongoing Challenges with Clinical Assessment of Nodal Status in T1 Esophageal Adenocarcinoma.
Nobel TB; Barbetta A; Hsu M; Tan KS; Sihag S; Bains MS; Jones DR; Molena D
J Am Coll Surg; 2019 Oct; 229(4):366-373. PubMed ID: 31108196
[TBL] [Abstract][Full Text] [Related]
2. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk.
Newton AD; Predina JD; Xia L; Roses RE; Karakousis GC; Dempsey DT; Williams NN; Kucharczuk JC; Singhal S
Ann Surg Oncol; 2018 Jan; 25(1):318-325. PubMed ID: 29147928
[TBL] [Abstract][Full Text] [Related]
3. Predicting lymph node metastases in early esophageal adenocarcinoma using a simple scoring system.
Lee L; Ronellenfitsch U; Hofstetter WL; Darling G; Gaiser T; Lippert C; Gilbert S; Seely AJ; Mulder DS; Ferri LE
J Am Coll Surg; 2013 Aug; 217(2):191-9. PubMed ID: 23659947
[TBL] [Abstract][Full Text] [Related]
4. Using the National Cancer Database to create a scoring system that identifies patients with early-stage esophageal cancer at risk for nodal metastases.
Weksler B; Kennedy KF; Sullivan JL
J Thorac Cardiovasc Surg; 2017 Nov; 154(5):1787-1793. PubMed ID: 28867381
[TBL] [Abstract][Full Text] [Related]
5. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma.
Cen P; Hofstetter WL; Correa AM; Wu TT; Lee JH; Ross WA; Davilla M; Swisher SG; Fukami N; Rashid A; Maru D; Ajani JA
Cancer; 2008 Mar; 112(5):1020-7. PubMed ID: 18205187
[TBL] [Abstract][Full Text] [Related]
6. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease.
Schölvinck D; Künzli H; Meijer S; Seldenrijk K; van Berge Henegouwen M; Bergman J; Weusten B
Surg Endosc; 2016 Sep; 30(9):4102-13. PubMed ID: 27357927
[TBL] [Abstract][Full Text] [Related]
7. Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience.
Graham D; Sever N; Magee C; Waddingham W; Banks M; Sweis R; Al-Yousuf H; Mitchison M; Alzoubaidi D; Rodriguez-Justo M; Lovat L; Novelli M; Jansen M; Haidry R
World J Gastroenterol; 2018 Nov; 24(41):4698-4707. PubMed ID: 30416317
[TBL] [Abstract][Full Text] [Related]
8. [Lymph node metastasis and prognostic factors for T1 esophageal cancer].
Duan XF; Shang XB; Tang P; Jiang HJ; Gong L; Yue J; Ma MQ; Yu ZT
Zhonghua Wai Ke Za Zhi; 2017 Sep; 55(9):690-695. PubMed ID: 28870055
[No Abstract] [Full Text] [Related]
9. Outcomes after endoscopic mucosal resection or esophagectomy for submucosal esophageal adenocarcinoma.
Nelson DB; Dhupar R; Katkhuda R; Correa A; Goltsov A; Maru D; Sepesi B; Antonoff MB; Mehran RJ; Rice DC; Vaporciyan AA; Davila M; Davila R; Betancourt S; Ajani J; Hofstetter WL
J Thorac Cardiovasc Surg; 2018 Jul; 156(1):406-413.e3. PubMed ID: 29605441
[TBL] [Abstract][Full Text] [Related]
10. A Model Based on Pathologic Features of Superficial Esophageal Adenocarcinoma Complements Clinical Node Staging in Determining Risk of Metastasis to Lymph Nodes.
Davison JM; Landau MS; Luketich JD; McGrath KM; Foxwell TJ; Landsittel DP; Gibson MK; Nason KS
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):369-377.e3. PubMed ID: 26515637
[TBL] [Abstract][Full Text] [Related]
11. Prediction of lymph node metastatic status in superficial esophageal squamous cell carcinoma using an assessment model combining clinical characteristics and pathologic results: A retrospective cohort study.
Zhou Y; Du J; Wang Y; Li H; Ping G; Luo J; Chen L; Zhang S; Wang W
Int J Surg; 2019 Jun; 66():53-61. PubMed ID: 31029876
[TBL] [Abstract][Full Text] [Related]
12. [FDG PET/CT versus PET alone for pre-surgical detection of lymph node metastasis in esophageal carcinoma].
Yuan SH; Yu JM; Yu YH; Fu Z; Guo HB; Liu TH; Yang XH; Yang GR; Li WW
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):221-4. PubMed ID: 17649642
[TBL] [Abstract][Full Text] [Related]
13. A prediction model for lymph node metastasis in T1 esophageal squamous cell carcinoma.
Wu J; Chen QX; Shen DJ; Zhao Q
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1902-1908. PubMed ID: 29233596
[TBL] [Abstract][Full Text] [Related]
14. What Constitutes Optimal Management of T1N0 Esophageal Adenocarcinoma?
Ramay FH; Vareedayah AA; Visrodia K; Iyer PG; Wang KK; Eluri S; Shaheen NJ; Reddy R; Martin LW; Greenwald BD; Edwards MA
Ann Surg Oncol; 2019 Mar; 26(3):714-731. PubMed ID: 30607765
[TBL] [Abstract][Full Text] [Related]
15. Risk prediction of occult lymph node metastasis in patients with clinical T1 through T2 N0 esophageal squamous cell carcinoma.
Yun JK; Kim HR; Park SI; Kim YH
J Thorac Cardiovasc Surg; 2022 Jul; 164(1):265-275.e5. PubMed ID: 34801263
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of T1b esophageal adenocarcinoma patients.
Tian J; Prasad GA; Lutzke LS; Lewis JT; Wang KK
Gastrointest Endosc; 2011 Dec; 74(6):1201-6. PubMed ID: 22000793
[TBL] [Abstract][Full Text] [Related]
17. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
[TBL] [Abstract][Full Text] [Related]
18. Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma.
Suzuki L; Ten Kate FJC; Gotink AW; Stoop H; Doukas M; Nieboer D; Spaander MCW; van Lanschot JJB; van Wijnhoven BPL; Koch AD; Bruno MJ; Looijenga LHJ; Biermann K
PLoS One; 2019; 14(7):e0219494. PubMed ID: 31283789
[TBL] [Abstract][Full Text] [Related]
19. Esophagectomy Outcomes in the Endoscopic Mucosal Resection Era.
Dickinson KJ; Wang K; Zhang L; Allen MS; Cassivi SD; Nichols FC; Shen R; Wigle DA; Blackmon SH
Ann Thorac Surg; 2017 Mar; 103(3):890-897. PubMed ID: 27964921
[TBL] [Abstract][Full Text] [Related]
20. Risk of lymph node metastasis in T1 esophageal adenocarcinoma: a meta-analysis.
Nguyen CL; Tovmassian D; Isaacs A; Falk GL
Dis Esophagus; 2024 Feb; ():. PubMed ID: 38391209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
